Filing Details

Accession Number:
0000899243-21-007812
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-23 16:30:18
Reporting Period:
2021-02-19
Accepted Time:
2021-02-23 16:30:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1521036 Lantheus Holdings Inc. LNTH In Vitro & In Vivo Diagnostic Substances (2835) 352318913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1788919 Christoph Heinz Maeusli C/O Lantheus Holdings, Inc.
331 Treble Cove Road
North Billerica MA 01862
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-19 1,000 $19.39 14,211 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020